Background Sarcopenia is defined as the loss of muscle mass combined with loss of muscle
strength, with or without loss of muscle performance. The use of this parameter as a risk …

Skeletal muscle loss, commonly known as sarcopenia, is highly prevalent and prognostic of
adverse outcomes in oncology. However, there is limited information on adults with early …

As populations continue to age worldwide, the impact of sarcopenia on public health will
continue to grow. The clinically relevant and increasingly common diagnosis of sarcopenia …

Background/Aim: Skeletal muscle mass loss is an emerging concern in oncology. Our
systematic review and meta-analysis identified the mean difference in skeletal muscle index …

Background The acute responses to cluster set resistance training (RT) have been
demonstrated. However, as compared to traditional sets, the effect of cluster sets on …

In the context of the management of the elderly patient with cancer, currently, a key topic
may be expressed by sarcopenia. Sarcopenia in its various definitions and ambiguities in …

Rationale Cancer is associated with muscle wasting. However, optimal protein intake has
not been determined, limiting the efficacy of nutritional interventions. This systematic review …

Low skeletal muscle mass is highly prevalent in older cancer patients and affects 5% to 89%
depending on the type and stage of cancer. Low skeletal muscle mass is associated with …

Purpose The aim of this study was to elucidate the clinical impact of skeletal muscle area
(SMA) in patients with non-small cell lung cancer (NSCLC) treated with anti-programmed …

Background Sarcopenia is associated with adverse outcomes among older adults with
cancer; however, no easily applied sarcopenia measure exists for use in clinical practice …